03/16/2022 Septerna emerges with $100M to spark ‘second golden age’ of prolific drug target GPCR with pioneer as co-founder Read More
03/16/2022 A new Third Rock startup seeks a ‘second golden age’ of GPCR drug discovery based on Nobel laureate’s work Read More
01/27/2022 Septerna Launches with $100 Million Series A Financing to Expand the Frontier of GPCR-targeted Medicines using the Native Complex™ Platform Read More